Abstract
Adiposity-related chronic diseases and cardiovascular-kidney-metabolic (CKM) syndrome significantly contribute to the burden of non-communicable diseases (NCDs), especially in low-and middle-income countries (LMICs), where early risk stratification is still inadequate. This study evaluated the efficacy of endothelin-1 (ET-1) and the triglyceride-to-high-density lipoprotein cholesterol (TG/HDL-C) ratio as early, cost-efficient biomarkers for cardiovascular risk assessment in persons with adiposity-based chronic disease (ABCD) and early-stage CKM syndrome.
| Original language | English |
|---|---|
| Pages (from-to) | 51-60 |
| Number of pages | 10 |
| Journal | Cor et Vasa |
| Volume | 68 |
| Issue number | 1 |
| DOIs | |
| Publication status | Published - 2026 |
Keywords
- Adiposity-based chronic disease
- Atherogenic index of plasma
- Cardiovascular risk assessment
- Cardiovascular-kidney-metabolic syndrome
- Endothelin-1
- Triglyceride-to-HDL cholesterol ratio
Fingerprint
Dive into the research topics of 'Pilot Evaluation of Endothelin-1 and TG/HDL-C Ratio for Early Cardiovascular Risk Stratification in Adiposity-Based and Cardiovascular-Kidney-Metabolic Syndromes'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver